← SynDRA
GSK 2830371
SynDRA canonical compound SYN1610927 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | PPM1D |
| Mechanism of action | protein phosphatase inhibitor |
All known targets
Mechanisms of action (all sources)
- PPM1D INHIBITOR
- protein phosphatase inhibitor
Cross-references
Synonyms
- GSK2830371
- gsk2830371
- GSK-2830371
- (S)-5-(((5-Chloro-2-methylpyridin-3-yl)amino)methyl)-N-(3-cyclopentyl-1-(cyclopropylamino)-1-oxopropan-2-yl)thiophene-2-carboxamide
- CHEMBL3613749
- 2-Thiophenecarboxamide, 5-[[(5-chloro-2-methyl-3-pyridinyl)amino]methyl]-N-[(1S)-1-(cyclopentylmethyl)-2-(cyclopropylamino)-2-oxoethyl]-
- 5-[[(5-chloro-2-methylpyridin-3-yl)amino]methyl]-N-[(2S)-3-cyclopentyl-1-(cyclopropylamino)-1-oxopropan-2-yl]thiophene-2-carboxamide
- (S)-5-{[(5-chloro-2-methylpyridin-3-yl)amino]methyl}-N-[3-cyclopentyl-1-(cyclopropylamino)-1-oxopropan-2-yl]thiophene-2-carboxamide
- SCHEMBL13739288
- GTPL11103
- BCP27848
- EX-A2687
- BDBM50118478
- s7573
- ZINC98210305
- AKOS024458513
- CCG-269347
- compound 8 [PMID: 24390428]
- NCGC00378628-07
- AC-36606
- AS-16421
- HY-15832
- EN300-179507
- A899200
- (2S)-2-[(5-{[(5-CHLORO-2-METHYLPYRIDIN-3-YL)AMINO]METHYL}THIOPHEN-2-YL)FORMAMIDO]-3-CYCLOPENTYL-N-CYCLOPROPYLPROPANAMIDE
- 5-[[(5-Chloro-2-methyl-3-pyridinyl)amino]methyl]-N-[(1S)-1-(cyclopentylmethyl)-2-(cyclopropylamino)-2-oxoethyl]-2-thiophenecarboxamide
- 5-[[(5-Chloro-2-methyl-3-pyridinyl)amino]methyl]-N-[(1S)-1-(cyclopentylmethyl)-2-(cycloprpylamino)-2-oxoethyl]-2-thiophenecarboxamide
- Gsk2830371
- RefChem:144554
- C23H29ClN4O2S
- GSK 2830371-d4
- MFCD28009442
- orb1300696
- GLXC-04456
- EGC45653
- EBC-12630
- NCGC00378628-05
- DA-73889
- GSK 2830371?
Look up GSK 2830371 in the interactive SynDRA portal →